Mast cell leukemia surgery
Jump to navigation
Jump to search
|
Mast cell leukemia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Mast cell leukemia surgery On the Web |
|
American Roentgen Ray Society Images of Mast cell leukemia surgery |
|
Risk calculators and risk factors for Mast cell leukemia surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nawal Muazam M.D.[2]
Overview
The predominant therapy for mast cell leukemia is immunochemotherapy. Surgical management, such as splenectomy or bone marrow transplantation may be required in certain cases.
Surgery
The predominant therapy for mast cell leukemia is immunochemotherapy. Surgical management, such as splenectomy or bone marrow transplantation may be required in certain cases.[1]
References
- ↑ Georgin-Lavialle, S.; Lhermitte, L.; Dubreuil, P.; Chandesris, M.-O.; Hermine, O.; Damaj, G. (2012). "Mast cell leukemia". Blood. 121 (8): 1285–1295. doi:10.1182/blood-2012-07-442400. ISSN 0006-4971.